MYXV encodes several known secreted anti-inflammatory proteins that inhibit myeloid cells, such as the SERP1 glycoprotein that is currently in clinical trial to inhibit systemic inflammation associated with myocardial disease (ADD REF: Tradiff et al, 2011). The gene discussed is SERP1; the disease is myocardial disorder.